Infectious Diseases News and Research

RSS

Study to determine lowest dose of chemotherapy needed for babies with SCID

Michael Pulsipher, MD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, along with co-principal investigator, Sung-Yun Pai, MD, of Boston Children's Hospital, has been awarded nearly $9 million from the National Institute of Allergy and Infectious Diseases of the NIH to study a new treatment approach for babies born with severe combined immunodeficiency (SCID) which prevents the immune system from functioning normally.

6 Oct 2017

Drinking plenty of water may reduce risk of UTIs in women prone to infection

Drinking an additional three pints of water a day may keep the urinary tract infection (UTI) away - at least for women who are prone - suggests a study being presented at IDWeek 2017.

6 Oct 2017

JAX professor receives $2.8 million New Innovator Award for skin microbiome research

Julia Oh, Ph.D., a Jackson Laboratory (JAX) assistant professor who explores the communities of microorganisms that live on the human skin, has received a special New Innovator Award of $2,835,000 from the National Institutes of Health (NIH) to explore how to develop engineered probiotic treatments for a variety of skin and infectious diseases.

5 Oct 2017

Antibody-based Zika virus therapeutic protects monkeys from infection, study shows

Using blood samples from an individual previously infected with Zika virus, scientists funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have developed an antibody-based Zika virus therapeutic that protected monkeys from infection.

5 Oct 2017

Scientists develop synthetic molecule effective at kicking and killing HIV

Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly reduce the chance of transmission from person to person.

5 Oct 2017

New DNA-based Zika vaccine demonstrates safety and ability to elicit immune response

A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans, according to new research from the Perelman School of Medicine at the University of Pennsylvania, conducted in partnership with The Wistar Institute, Inovio Pharmaceuticals, and GeneOne Life Science, Inc.

5 Oct 2017

Light-activated nanoparticles can provide crucial boost in effectiveness for antibiotics

Light-activated nanoparticles, also known as quantum dots, can provide a crucial boost in effectiveness for antibiotic treatments used to combat drug-resistant superbugs such as E. coli and Salmonella, new University of Colorado Boulder research shows.

4 Oct 2017

Researchers awarded NIH grant to develop, test new drugs for treating Giardia infections

The microscopic parasite Giardia can be found within Idaho, every region of the U.S. and around the world. While Giardia is not considered fatal, anyone who has suffered from the diarrheal disease knows how uncomfortable it can be.

3 Oct 2017

Statin use linked to reduced risk of S aureus bloodstream infection

Users of statins, widely prescribed for prevention of cardiac disease, have a 27% lower risk of contracting a Staphylococcus aureus (S aureus) bloodstream infection outside of a hospital, according to a new study in Mayo Clinic Proceedings.

3 Oct 2017

GM mosquitoes can have altered microbiota that suppresses human malaria-causing parasites

WHAT: Using genetically modified (GM) mosquitoes to reduce or prevent the spread of infectious diseases is a new but rapidly expanding field of investigation.

30 Sep 2017

University of Hawaii researcher receives $6.3 million grant for trivalent Ebola vaccine development

University of Hawaii vaccine researcher Axel Lehrer, PhD, has received a nearly $6.3 million grant to test whether the Ebola vaccine formula he has developed will protect against two additional viruses in the same family.

28 Sep 2017

Novartis partners with UC Berkeley to pursue 'undruggable' disease targets

Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pursuing the vast number of disease targets in cancer and other illnesses that have eluded traditional small-molecule compounds and are considered "undruggable."

28 Sep 2017

Achieving treatment targets of National HIV/AIDS Strategy would prevent new infections and deaths

An analysis led by a team of Massachusetts General Hospital investigators shows that achieving the treatment targets of the National HIV/AIDS Strategy by 2020 not only would prevent hundreds of thousands of new infections and deaths but also would demonstrate excellent value.

28 Sep 2017

Northumbria researcher develops new, faster and safer way to diagnose Ebola virus

A new, faster and safer way of diagnosing the Ebola virus has been developed by an academic from Northumbria University, Newcastle.

28 Sep 2017

High-speed method generates mini-protein binders with potential to become new class of drugs

Scientists have created a high-speed method to generate thousands of different, small, stable proteins from scratch that can be custom-designed to bind to specific therapeutic targets.

27 Sep 2017

Columbia University receives $9.6 million NIH grant for ME/CFS research center

The National Institutes of Health has awarded a five-year $9.6 million grant to the Center for Infection and Immunity at Columbia University's Mailman School of Public Health to create the Center for Solutions for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (CfS for ME/CFS), an inter-disciplinary, inter-institutional research group dedicated to understanding the biology of the disease in order to develop effective means to diagnose, treat and prevent it.

27 Sep 2017

Infectious Diseases News and Research

Study to determine lowest dose of chemotherapy needed for babies with SCID

Drinking plenty of water may reduce risk of UTIs in women prone to infection

JAX professor receives $2.8 million New Innovator Award for skin microbiome research

Antibody-based Zika virus therapeutic protects monkeys from infection, study shows

Scientists develop synthetic molecule effective at kicking and killing HIV

New DNA-based Zika vaccine demonstrates safety and ability to elicit immune response

Light-activated nanoparticles can provide crucial boost in effectiveness for antibiotics

Researchers awarded NIH grant to develop, test new drugs for treating Giardia infections

Statin use linked to reduced risk of S aureus bloodstream infection

GM mosquitoes can have altered microbiota that suppresses human malaria-causing parasites

University of Hawaii researcher receives $6.3 million grant for trivalent Ebola vaccine development

Novartis partners with UC Berkeley to pursue 'undruggable' disease targets

Achieving treatment targets of National HIV/AIDS Strategy would prevent new infections and deaths

Northumbria researcher develops new, faster and safer way to diagnose Ebola virus

High-speed method generates mini-protein binders with potential to become new class of drugs

Columbia University receives $9.6 million NIH grant for ME/CFS research center

Scientists gain insight into how Ebola virus uses the body's defenses to speed up infection

Antibiotics reduce risk of recurrent staph infections in children, research shows

Positive mood on the day of flu jab can increase its protective effect, research finds

Study: Antibody neutralizes dengue and Zika virus in mice

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News